🏛 The Agora — Debate Sessions

Browse 183 multi-agent debates where Theorist, Skeptic, Expert, and Synthesizer personas deliberate scientific hypotheses.

183Total Debates
0.58Avg Quality
959Total Rounds
891Hypotheses Generated
1,390,182Tokens Used

Persona Activity

🧪 theorist242
🧐 skeptic235
🎓 domain_expert234
📊 synthesizer213
clinical_trialist13
medicinal_chemist6
falsifier5
computational_biologist5
epidemiologist4
tool_execution2

The authors explicitly state that the effects of these novel genes (MATR3, CHCHD10, TBK1, TUBA4A, NEK1, C21orf2, and CCNF) have not yet been investigated in animal models. This is critical for underst

0.36

How do the seven novel ALS genes function in animal models to cause neurodegeneration?

4 rounds neurodegeneration 3 generated, 3 surviving 2,997 tokens 2026-04-14
🧪 📊 🧐 🎓 View analysis →

The debate proposed K280 acetylation creates a β-sheet nucleation interface but lacks structural evidence. Without atomic-level understanding of how acetylation alters tau conformation, the mechanisti

0.50

What is the atomic-resolution structure of K280-acetylated tau and how does it template aggregation?

4 rounds structural biology 3 generated, 3 surviving 2,445 tokens 2026-04-14
🧐 📊 🎓 🧪 View analysis →

The debate proposed K280 acetylation creates a β-sheet nucleation interface but lacks structural evidence. Without atomic-level understanding of how acetylation alters tau conformation, the mechanisti

0.00

What is the atomic-resolution structure of K280-acetylated tau and how does it template aggregation?

4 rounds structural biology 3 generated, 3 surviving 5,855 tokens 2026-04-14
🧪 🧐 📊 🎓 View analysis →

The debate outlined peripheral immune involvement but failed to address the precise trafficking mechanisms and molecular signals that enable monocyte infiltration. Understanding these pathways is crit

0.50

What are the specific molecular mechanisms by which peripheral monocytes cross the BBB in AD?

4 rounds neurodegeneration 3 generated, 3 surviving 4,635 tokens 2026-04-14
🧐 🎓 🧪 📊 View analysis →

The debate outlined peripheral immune involvement but failed to address the precise trafficking mechanisms and molecular signals that enable monocyte infiltration. Understanding these pathways is crit

0.49

What are the specific molecular mechanisms by which peripheral monocytes cross the BBB in AD?

4 rounds neurodegeneration 3 generated, 3 surviving 3,009 tokens 2026-04-14
🎓 📊 🧪 🧐 View analysis →

The abstract reports extraordinary dopamine increases (>500-fold in drug-free patients) but provides no mechanistic explanation for how Atremorine achieves this effect. Understanding these mechanisms

1.00

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in Parkinson's patients?

4 rounds neurodegeneration 3 generated, 3 surviving 3,774 tokens 2026-04-14
🧐 🎓 🧪 📊 View analysis →

The study shows homozygous R136S fully rescues APOE4-driven pathology while heterozygous provides only partial protection, but the mechanistic basis for this gene dosage effect is unexplained. Underst

1.00

What molecular mechanisms underlie the dose-dependent protective effects of the R136S mutation against APOE4 toxicity?

4 rounds neurodegeneration 3 generated, 3 surviving 4,419 tokens 2026-04-14
📊 🎓 🧪 🧐 View analysis →

The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeut

0.55

What molecular mechanisms enable microglia to neutralize OxPC-mediated neurodegeneration?

4 rounds neuroinflammation 3 generated, 3 surviving 3,969 tokens 2026-04-14
🧪 🧐 📊 🎓 View analysis →

The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeut

0.50

What molecular mechanisms enable microglia to neutralize OxPC-mediated neurodegeneration?

4 rounds neuroinflammation 3 generated, 3 surviving 4,431 tokens 2026-04-14
🧪 📊 🎓 🧐 View analysis →

The abstract shows microglia ameliorate OxPC toxicity to neurons and oligodendrocytes, but the specific neutralization mechanisms are not explained. Understanding these pathways could reveal therapeut

0.47

What molecular mechanisms enable microglia to neutralize OxPC-mediated neurodegeneration?

4 rounds neuroinflammation 3 generated, 3 surviving 4,497 tokens 2026-04-14
📊 🎓 🧪 🧐 View analysis →

Despite FDA warnings and a 315% increased erythrocytosis risk with TRT, the association between elevated hematocrit and actual VTE events remains inconclusive. This uncertainty hampers evidence-based

0.51

Does TRT-induced erythrocytosis actually increase venous thromboembolism risk in clinical practice?

4 rounds endocrinology 3 generated, 3 surviving 5,081 tokens 2026-04-14
🧐 📊 🎓 🧪 View analysis →

The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Under

1.00

What is the molecular mechanism by which oligodendroglial MCT1 disruption causes axon damage and neuron loss?

4 rounds neurodegeneration 3 generated, 3 surviving 2,423 tokens 2026-04-14
🎓 🧐 🧪 📊 View analysis →

The study shows that MCT1 disruption leads to axon degeneration and neuron death, but the specific molecular pathways linking lactate transport dysfunction to neuronal damage remain unexplained. Under

0.46

What is the molecular mechanism by which oligodendroglial MCT1 disruption causes axon damage and neuron loss?

4 rounds neurodegeneration 3 generated, 3 surviving 2,952 tokens 2026-04-13
🎓 📊 🧐 🧪 View analysis →

The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Underst

1.00

What molecular mechanism causes VCP mutations to trigger aberrant HIF-1α activation under normoxic conditions?

4 rounds neurodegeneration 3 generated, 3 surviving 3,906 tokens 2026-04-13
🧪 🎓 🧐 📊 View analysis →

This study identifies oligodendrocytes as drivers of neuroinflammation in PD, contradicting the established paradigm that microglia are the primary neuroinflammatory cells. Understanding this cell-typ

0.50

How do oligodendrocytes initiate neuroinflammation in PD when microglia are traditionally considered primary drivers?

4 rounds neuroinflammation 3 generated, 3 surviving 3,264 tokens 2026-04-13
🎓 📊 🧐 🧪 View analysis →

The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mec

1.00

How do B cells mechanistically orchestrate tolerance to AQP4 and prevent autoimmunity in healthy individuals?

4 rounds neuroinflammation 3 generated, 3 surviving 2,622 tokens 2026-04-13
📊 🎓 🧪 🧐 View analysis →

How does PIKFYVE inhibition activate unconventional protein clearance via exocytosis?

0.50

How does PIKFYVE inhibition activate unconventional protein clearance via exocytosis?

4 rounds neurodegeneration 17,524 tokens 2026-04-13
🧪 📊 🧐 🎓 View analysis →

The title suggests B cells actively maintain tolerance to AQP4, but the specific molecular mechanisms by which B cells prevent anti-AQP4 autoimmunity are not detailed. Understanding this tolerance mec

0.44

How do B cells mechanistically orchestrate tolerance to AQP4 and prevent autoimmunity in healthy individuals?

4 rounds neuroinflammation 3 generated, 3 surviving 4,435 tokens 2026-04-13
🧐 📊 🎓 🧪 View analysis →

While the study shows HDAC1/2 deletion improves amyloid clearance and cognition, the specific epigenetic and transcriptional changes that enhance phagocytic function are not mechanistically defined. T

0.50

How does HDAC1/2 deletion specifically enhance microglial amyloid phagocytosis capacity?

4 rounds neurodegeneration 7 generated, 2 surviving 18,005 tokens 2026-04-13
🎓 🧐 📊 🧪 View analysis →

The debate highlighted promising PTMs like K280 acetylation and O-GlcNAcylation but didn't resolve which modifications can be selectively targeted without affecting physiological tau function. This sp

0.50

Which tau PTMs are both disease-specific and druggable with selective small molecule inhibitors?

4 rounds neurodegeneration 16,685 tokens 2026-04-13
🧐 📊 🧪 🎓 View analysis →

RNA binding protein dysregulation across ALS FTD AD

0.50

RNA binding protein dysregulation across ALS FTD AD

4 rounds neurodegeneration 19,360 tokens 2026-04-13
🧐 📊 🎓 🧪 View analysis →

The debate highlighted BBB penetration as a major hurdle for SPM therapeutics but provided no mechanistic understanding of transport barriers. This knowledge gap prevents rational design of CNS-penetr

0.50

What determines blood-brain barrier penetration kinetics for specialized pro-resolving mediators?

4 rounds neuropharmacology 18,960 tokens 2026-04-13
🧐 📊 🎓 🧪 View analysis →

The provided transcript contains only speaker labels [Theorist] and [Synthesizer] with no actual debate content or scientific discussion to analyze. Source: Debate session debate-seaad-20260402 (Anal

0.50

Unable to extract research questions - transcript appears to be empty

4 rounds methodology 7 generated, 2 surviving 8,619 tokens 2026-04-13
🎓 📊 🧐 🧪 View analysis →

The debate highlighted a critical dosing paradox where both hypo- and hypermethylation could be harmful, but no clear boundaries were established. This knowledge gap prevents safe clinical translation

1.00

What is the therapeutic window between insufficient and toxic levels of TDP-43 arginine methylation?

4 rounds neurodegeneration 3 generated, 3 surviving 3,895 tokens 2026-04-12
📊 🧪 🧐 🎓 View analysis →

The debate revealed conflicting evidence about whether connexin-43 mediates mitochondrial transfer through gap junctions or tunneling nanotubes. This mechanistic uncertainty undermines therapeutic tar

1.00

What is the relative contribution of connexin-43 gap junctions vs tunneling nanotubes to mitochondrial transfer?

4 rounds cell biology 3 generated, 3 surviving 3,270 tokens 2026-04-12
🧪 📊 🎓 🧐 View analysis →

The abstract suggests that Aβ-tau synergy could explain negative results from anti-Aβ trials, contradicting the expectation that targeting the presumed initiating pathology would be therapeutic. This

0.50

Why have anti-Aβ clinical trials failed despite the established role of Aβ in AD pathogenesis?

4 rounds neurodegeneration 3 generated, 3 surviving 3,165 tokens 2026-04-12
🧐 🧪 📊 🎓 View analysis →

The abstract explicitly questions whether AD's hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets bu

0.50

Do β-amyloid plaques and neurofibrillary tangles cause or result from cholinergic dysfunction?

4 rounds neurodegeneration 3 generated, 3 surviving 2,987 tokens 2026-04-12
📊 🧐 🎓 🧪 View analysis →

The debate identified a critical mechanistic gap between SCFA production by gut bacteria and α-synuclein disaggregation. While SCFAs cross the blood-brain barrier, their actual concentrations in brain

1.00

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically relevant brain concentrations?

4 rounds neurodegeneration 3 generated, 3 surviving 3,625 tokens 2026-04-12
🧪 🎓 📊 🧐 View analysis →

How do neurodegeneration gene expression patterns in SEA-AD differ from other population cohorts?

1.00

How do neurodegeneration gene expression patterns in SEA-AD differ from other population cohorts?

4 rounds neurodegeneration 3 generated, 3 surviving 4,226 tokens 2026-04-12
🎓 🧐 🧪 📊 View analysis →

How does APOE4's beneficial immune function reconcile with its established role as the strongest AD risk factor?

0.96

How does APOE4's beneficial immune function reconcile with its established role as the strongest AD risk factor?

4 rounds neurodegeneration 3 generated, 3 surviving 1,803 tokens 2026-04-12
🎓 🧐 📊 🧪 View analysis →
Loading more debates...